Ibrutinib & The Really Bad No Good Terrible Ra... - CLL Support

CLL Support

24,052 members•40,916 posts

Ibrutinib & The Really Bad No Good Terrible Rash on My Leg

•19 Replies

You need to be a member of this community to see this post.

19 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Update on my skin rash

Went dermatology today at my local hospital after being referred by my GP about the terrible rash I...
cartwheels profile image
cartwheels
•
14 Replies

Rash on hands (Erythematous rash to the hypothenar eminence)

Hello y'all....it has been some time since I have posted anything. My eight months on ibrutinib...
jdolinger profile image
jdolinger
•
13 Replies

THE GOOD THE BAD AND THE UGLY

Hi everyone. I have some recent results I wanted to share with you regarding the clinical trial I'm...
BCTexas profile image
BCTexas
•
63 Replies

Rash continues 6 months after treatment

Hi, I finished my Gazyva treatment in December 2016. During the last few months of treatment I...
skinkade profile image
skinkade
•
9 Replies

Can anyone confirm if Ibrutinib is now available on prescription in the UK?

I just received an email from a friend to suggest it is available. I’m to start 6 months of BR...
Ruhi9 profile image
Ruhi9
•
14 Replies

Related Posts

Moderation team

See all
AussieNeil profile image
AussieNeilAdministrator
Newdawn profile image
NewdawnAdministrator
CLLerinOz profile image
CLLerinOzAdministrator

Popular Posts

profile image
RSV Vaccine, Should this be offered to someone diagnosed wit...
profile image
CT shock
profile image
Back to the drawing board
profile image
Am I covered
profile image
opinions on best treatment options and what tests to expect ...

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.